MAKENA (hydroxyprogesterone caproate)
RISK REDUCTION FOR RECURRENT PRETERM BIRTH
LUMARA HEALTH/A
Indication
Risk reduction for recurrent preterm birth
Risk reduction for recurrent preterm birth refers to clinical interventions aimed at preventing repeat delivery before 37 completed weeks of gestation in pregnant individuals with a documented history of prior spontaneous preterm delivery or second-trimester loss. Read more about Risk reduction for recurrent preterm birth
13 drugs 9 manufacturers
Drugs that treat it
Common Risk reduction for recurrent preterm birth therapies.
MAKENA (hydroxyprogesterone caproate/PF)
RISK REDUCTION FOR RECURRENT PRETERM BIRTH
AMAG PHARMACEUT
HYDROXYPROGESTERONE CAPROATE
RISK REDUCTION FOR RECURRENT PRETERM BIRTH
PRASCO LABS
HYDROXYPROGESTERONE CAPROATE
RISK REDUCTION FOR RECURRENT PRETERM BIRTH
SLAYBACK PHARMA
HYDROXYPROGESTERONE CAPROATE (hydroxyprogesterone caproate/PF)
RISK REDUCTION FOR RECURRENT PRETERM BIRTH
PRASCO LABS
HYDROXYPROGESTERONE CAPROATE (hydroxyprogesterone caproate/PF)
RISK REDUCTION FOR RECURRENT PRETERM BIRTH
SLAYBACK PHARMA
HYDROXYPROGESTERONE CAPROATE (hydroxyprogesterone caproate/PF)
RISK REDUCTION FOR RECURRENT PRETERM BIRTH
American Regent
HYDROXYPROGESTERONE CAPROATE (hydroxyprogesterone caproate/PF)
RISK REDUCTION FOR RECURRENT PRETERM BIRTH
Amneal Pharmaceuticals
HYDROXYPROGESTERONE CAP(PPRES) (hydroxyprogesterone caproate)
RISK REDUCTION FOR RECURRENT PRETERM BIRTH
EUGIA US LLC
Filter & compare in the drug finder →Opens the drug finder with Risk reduction for recurrent preterm birth preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRisk reduction for recurrent preterm birth refers to clinical interventions aimed at preventing repeat delivery before 37 completed weeks of gestation in pregnant individuals with a documented history of prior spontaneous preterm delivery or second-trimester loss.
Affecting the female reproductive system and the fetoplacental unit, this high-risk obstetric state is driven by multifactorial mechanisms that precipitate premature parturition.
Defining pathophysiologic processes include premature cervical remodeling or shortening, pathologic uterine contractility, subclinical intra-amniotic inflammation, decidual hemorrhage, and preterm prelabor rupture of membranes.
Because a prior preterm delivery significantly multiplies the baseline risk of subsequent early parturition, targeted prevention strategies aim to maintain uterine quiescence and cervical integrity to optimize gestational age at delivery.
- smfm.org
Risk reduction for recurrent preterm birth refers to clinical interventions aimed at preventing repeat delivery before 37 completed weeks of gestation in pregnant individuals with a documented history of prior spontaneous preterm delivery or second-trimester loss Because a prior preterm delivery significantly multiplies the baseline risk of subsequent early parturition, targeted prevention strategies aim to maintain uterine quiescence and cervical integrity to optimize gestational age at deliver...
- nih.gov
Risk reduction for recurrent preterm birth refers to clinical interventions aimed at preventing repeat delivery before 37 completed weeks of gestation in pregnant individuals with a documented history of prior spontaneous preterm delivery or second-trimester loss Affecting the female reproductive system and the fetoplacental unit, this high-risk obstetric state is driven by multifactorial mechanisms that precipitate premature parturition Defining pathophysiologic processes include premature cerv...
- bu.edu
Risk reduction for recurrent preterm birth refers to clinical interventions aimed at preventing repeat delivery before 37 completed weeks of gestation in pregnant individuals with a documented history of prior spontaneous preterm delivery or second-trimester loss
- smfm.org
Affecting the female reproductive system and the fetoplacental unit, this high-risk obstetric state is driven by multifactorial mechanisms that precipitate premature parturition Defining pathophysiologic processes include premature cervical remodeling or shortening, pathologic uterine contractility, subclinical intra-amniotic inflammation, decidual hemorrhage, and preterm prelabor rupture of membranes
- nih.gov
Defining pathophysiologic processes include premature cervical remodeling or shortening, pathologic uterine contractility, subclinical intra-amniotic inflammation, decidual hemorrhage, and preterm prelabor rupture of membranes
- utah.edu
Because a prior preterm delivery significantly multiplies the baseline risk of subsequent early parturition, targeted prevention strategies aim to maintain uterine quiescence and cervical integrity to optimize gestational age at delivery
Personalize your experience
Follow Risk reduction for recurrent preterm birth and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.